Search for: "Eli Lilly "
Results 801 - 820
of 2,131
Sorted by Relevance
|
Sort by Date
21 Aug 2015, 1:33 pm
Eli Lilly & Co., 2015 U.S. [read post]
18 Mar 2015, 7:00 am
Check and mate – summary judgment for Lilly. [read post]
17 Feb 2018, 7:31 am
Continued from Part IInfringement - no role for German doctrine of "deliberate selection" following Eli Lilly v Actavis, yet...On the basis of a normal interpretation, the shear mode fell within the scope of the claims. [read post]
14 Jul 2014, 11:28 am
Indianapolis, Indiana - An Indiana patent attorney for Eli Lilly and Company of Indianapolis, Indiana; Daiichi Sankyo Co., Ltd of Tokyo, Japan; Daiichi Sankyo, Inc. of Parsippany, New Jersey; and Ube Industries, Ltd. of Yamaguchi, Japan sued in the Southern District of Indiana alleging that HEC Pharm Co., Ltd. of China and HEC Pharm USA Inc. of Princeton, New Jersey (collectively, "HEC Pharm") infringed Lilly's patented Effient® product, Patent No.… [read post]
19 Jan 2018, 3:58 am
Readers interested in patent law will be familiar with last summer's decision of the UK Supreme Court in Actavis v Eli Lilly [2017] UKSC 48. [read post]
27 Oct 2015, 11:41 am
Eli Lilly, 2015 U.S. [read post]
28 Feb 2013, 8:10 am
Eli Lilly & Co., 577 F. [read post]
9 Nov 2017, 1:55 am
Entrance to the Swiss Federal Supreme CourtSince we are on the topic of K = Na, here a short update on the Swiss arm of the litigation.The Swiss Federal Patent Court considered the prosecution history and denied infringement of Eli Lilly’s patent by equivalent means because of the limitation introduced by the patentee during the examination. [read post]
25 Jul 2009, 12:32 am
Eli Lilly, where a federal district court, ignoring three state intermediate court cases, predicted that New Mexico would expand tort liability by not following the learned intermediary rule.Well, that judge recused himself for unstated reasons, and another judge got the case. [read post]
17 Nov 2022, 6:00 pm
Recent Headlines in the IP World: Blake Brittain: Google Must Face Uniloc Patent Lawsuits Again – Appeals Court (Source: Reuters) Zac Hall: Apple Settles With Firm In AirPods Patent Case On Jury Selection Day After Previous Mistrial (Source: 9to5 Mac) Blake Brittain: Eli Lilly Ordered To Pay $176.5 Million To Teva In U.S. [read post]
18 May 2020, 1:30 pm
Krishna Ravi Srinivas: Intellectual Property Rights and Innovation in the Times of Corona Epidemic – Policy Brief (Source: SSRN) New Job Postings on Patently-O: Harrity & Harrity, LLP 2SPL Patent Attorneys Davidson Sheehan LLP Osha Liang LLP Dority & Manning Klemchuk LLP Eli Lilly & Company McNeill Baur PLLC Caldwell Intellectual Property Law Klarquist Sparkman, LLP [read post]
16 Sep 2019, 2:10 am
The referral, but unfortunately not the referred question, has now been answered by the CJEU with its order in Eli Lilly v. [read post]
7 Jun 2019, 10:22 am
by Dennis Crouch Eli Lilly and Company v. [read post]
12 Jan 2023, 4:23 pm
Aug. 31, 2016) (issuing letter of request where witness was located in Italy and possessed evidence that was relevant and unlikely to be duplicative); Eli Lilly & Co. v. [read post]
9 May 2024, 9:01 am
Novo Nordisk and Eli Lilly are facing dozens of lawsuits filed by people who developed severe complications after taking their GLP-1 RA medications, often requiring hospitalization or immediate medical intervention. [read post]
31 Oct 2017, 12:05 am
Patent practitioners have been speculating in recent weeks about what the Actavis v Eli Lilly Supreme Court judgment means in practice and how that decision might be applied. [read post]
29 Jan 2021, 10:26 am
Eli Lilly’s antibody seems to fare poorly against the South African variant (B.1351), though testing is underway. [read post]
26 Aug 2011, 7:28 am
Eli Lilly & Co., ___ F.3d ___, 2011 WL 3625105, slip op. (2d Cir. [read post]
1 Apr 2011, 12:42 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
21 Nov 2018, 12:04 pm
We begin this week with an update on the pemetrexed (Alimta) Italian patent case between Fresenius Kabi and Eli Lilly.Pemetrexed disodium at the Court of MilanLast year, IPKat blogged about the Court of Milan's decision in the pemetrexed (Alimta) patent case (Court of Milan, 12 September 2017, urgent proceedings between Fresenius Kabi and Eli Lilly).That decision has now been fully reversed by a panel of three judges of the same Court of… [read post]